Skip to main content
OpenTrials
Completed

NCT Number: NCT06149221

Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss

In-office applied non-thermal atmospheric pressure plasma treatment on NS pretreated scalp

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Androgenetic Alopecia Alopecia Hair Diseases Hypotrichosis Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Skin Center Dermatology Group

New City, New York, 10956, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • diagnosis of mild-to moderate androgenetic alopecia
  • ability to keep in-person follow-up appointments

Exclusion criteria

  • any inflammatory scalp condition
  • starting or discontinuing any hair loss treatments within 6 months of start date
  • allergy to any components of the carrier solution

Treatment and study plan

NTAP

Device

Cold plasma is generated and applied to the scalp area, which was previously soaked with normal saline

Primary outcomes

  1. Presence of detectable hair growth

    Time frame: 3 months and 6 months

    Presence of hair growth as measured using the HairMetrix device

Secondary outcomes

  1. Adverse effects related to the treatment

    Time frame: throughout study completeion, 6 months

    Patients are monitored for adverse effects, including but not limited to irritation, itch, inflammation, scaling, redness, rash, peeling, blistering

Sponsors and collaborators

Lead sponsor

Dr. Peter C. Friedman

Industry

Registry information

Official study title

Using Direct Non-thermal Atmospheric Pressure Plasma With Penetration Enhancement for the Treatment of Hair Loss

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Nov 28, 2023
Registry last updated
Apr 17, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.